Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?

Author:
  • Carl Borrebaeck
Publishing year: 2012
Language: English
Pages: 343-345
Publication/Series: Proteomics Clinical Applications
Volume: 6
Issue: 7-8
Document type: Journal article
Publisher: John Wiley & Sons

Abstract english

Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patterns associated with different diseases. The study design is then crucial and sample quality, bioinformatic approaches, pre-validation, using independent patient cohort, need to attract increased attention before proteomics will contribute to the needs of personalized medicine.

Keywords

  • Cell and Molecular Biology
  • over-fitting
  • biobanks
  • pre-validation
  • bioinformatics
  • Signatures

Other

Published
  • ISSN: 1862-8354
Carl Borrebaeck
E-mail: carl [dot] borrebaeck [at] immun [dot] lth [dot] se

Professor

Department of Immunotechnology

313k1

90

Director

Create Health

+46 46 222 96 13

313k1

90